The Truth Behind 10 Common Skin Cancer Myths

Skin cancer can affect anyone, no matter the color of your skin or even your age. Even celebrities like John Cena and Khloe Kardashian have shared their recent experiences with skin cancer.
For Melanoma Monday, Marc Hurlbert, PhD, CEO of the Melanoma Research Alliance (MRA), debunks 10 of the most common skin cancer misconceptions and explains how to lower your risk of skin cancer and how to catch it early.
Myth 1: There’s Only 1 Type of Skin Cancer
There are several different types of skin cancer, and some are more serious than others.
Myth 2: Melanoma Is Just a Mole That Needs to Be Removed
“But it’s so much more than a mole that needs to be removed,” Hurlbert says. “It can be deadly if it’s not dealt with early.”

Myth 3: Melanoma Appears Only on the Skin
- Asymmetry
- Borders that are irregular
- Colors that vary
- Diameter larger than a pencil eraser
- Evolving shape, size, or color
“We all know our own bodies better than even our doctors. We should all be aware of the marks on our own bodies,” Hurlbert says. “You get more of those as you age, but if they’re changing, be screened by a doctor.”

Myth 4: Skin Cancer Isn’t Serious
Skin cancer, particularly melanoma, can be deadly if it isn’t caught early.
“Melanoma has a propensity to spread to other parts of the body,” Hurlbert says.
Myth 5: People With Darker Skin Don’t Get Skin Cancer
“People of any race or skin color can get skin cancer from UV, period,” Hurlbert says.
Skin cancer may appear differently on darker skin, however, and Hurlbert says it may be missed more frequently in people of color.
Myth 6: You’ll Develop Melanoma Only if You’ve Had Years of Sun Exposure and Burns
Myth 7: A Tan From a Tanning Bed Protects You From Sunburns and Skin Cancer
No tan is healthy, Hurlbert says.
“A tan is actually a sign that your skin is in distress. It’s the skin’s damage or stress response to UV exposure,” he says.
Myth 8: Makeup Can Provide All the Skin Protection You Need
“It’s great that some makeups and foundations have SPF in them, but it’s not enough,” Hurlbert says. “You really want to put apply SPF 30 or higher and put on your makeup, then reapply every couple of hours.”
Myth 9: Sunscreen Is Only Needed When You’re Outside for Hours, Like at the Beach or the Pool
Sunscreen should be part of everyone’s morning routine, even if they’re going to be indoors for most of the day, Hurlbert says.
“You may be outside during your commute, and you can get sun exposure through windows while you’re inside, too,” he says.
When you’re outside for an extended period of time, you need to reapply sunscreen every two hours, he says.
Myth 10: Only UV Exposure Causes Skin Cancer
“Skin cancer can run in families,” Hurlbert says. “We haven’t yet identified the inherited genetics of melanoma, but there are hints of what genes may be involved.”
The Takeaway
- Skin cancer affects 1 in 5 U.S. adults.
- Melanoma is the deadliest form of skin cancer, but it’s not the most common.
- Exposure to UV rays from the sun or from tanning beds is the most common cause of skin cancer.
- Detection and early treatment are key to keeping skin cancer under control.
Resources We Trust
- Cleveland Clinic: Skin Cancer
- American Academy of Dermatology: What to Look For: ABCDEs of Melanoma
- American Cancer Society: Melanoma Skin Cancer
- Centers for Disease Control and Prevention: Skin Cancer Basics
- National Institutes of Health: Keep Your Skin Healthy
- Skin Cancer Basics. Centers for Disease Control and Prevention. July 1, 2024.
- Key Statistics for Basal and Squamous Cell Skin Cancers. American Cancer Society. October 31, 2023.
- Key Statistics for Melanoma Skin Cancer. American Cancer Society. January 16, 2025.
- Melanoma. Mayo Clinic. December 30, 2023.
- Cymerman RM et al. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival. Journal of the National Cancer Institute. October 2016.
- What to Look For: ABCDEs of Melanoma. American Academy of Dermatology.
- Treatment of Melanoma Skin Cancer, by Stage. American Cancer Society. February 21, 2024.
- Radiation Therapy for Basal and Squamous Cell Skin Cancers. American Cancer Society. October 31, 2023.
- Skin Cancer in People of Color. Skin Cancer Foundation.
- Hu S et al. Comparison of Stage at Diagnosis of Melanoma Among Hispanic, Black, and White Patients in Miami-Dade County, Florida. Archives of Dermatology. June 2006.
- Bradford PT. Skin Cancer in Skin of Color. Dermatology Nursing. July–August 2009.
- Sunburn and Your Skin. Skin Cancer Foundation.
- An S et al. Indoor Tanning and the Risk of Overall and Early-Onset Melanoma and Non-Melanoma Skin Cancer: Systematic Review and Meta-Analysis. Cancers. November 25, 2021.
- Does a “Base Tan” Protect Your Skin From Sunburn? University of Central Florida.
- Sunscreen FAQs. American Academy of Dermatology. February 11, 2025.
- Skin Cancer Facts and Statistics. Skin Cancer Foundation. January 2025.
- Genetics of Skin Cancer (PDQ®) — Health Professional Version. National Cancer Institute. January 3, 2025.
- Skin Cancer Risk Factors. Centers for Disease Control and Prevention. July 1, 2024.

Daniel Landau, MD
Medical Reviewer
Daniel Landau, MD, is a distinguished board-certified hematologist-oncologist with a career that has spanned two eminent institutions: the Orlando Health Cancer Institute and the Medical University of South Carolina. With a specialized interest in genitourinary oncology and hematology, he has been at the forefront of managing both benign and malignant conditions.
Dr. Landau is a pioneering figure in integrating advanced technology into oncology, having served as a director of telemedicine services. Under his leadership, multiple innovative systems have been designed and piloted, all with a singular focus: enhancing the patient experience.
Beyond his clinical and technological endeavors, Landau is deeply committed to medical education. He has dedicated significant time and expertise to nurturing the skills of medical students, residents, and fellows, ensuring that the flame of knowledge and compassion burns bright in the next generation of oncologists.
